Erlotinib Completed Phase 1 Trials for Cancer, Advanced Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01287546 | A Study of LY2875358 in Participants With Advanced Cancer | |
| NCT00895687 | Study of Erlotinib in Combination With Bortezomib | |
| NCT00895128 | Study of Erlotinib in Combination With Dasatinib |